'Why we do What we do in Cardiology'
ചാനൽ വിവരങ്ങൾ
'Why we do What we do in Cardiology'
I am Dr. Bishnu Subedi. I am a cardiologist in the United States. In the era of evidence-based medicine, our practice is usually guided by a scientific study, expert society statements, or clinical guidelines. In this podcast series, I intend to highlight some of these practice-changing articles in...
സമീപകാല എപ്പിസോഡുകൾ
35 എപ്പിസോഡുകൾ
REDUCE-AMI Trial: Diminishing Role of Beta-Blockers in ACS with preserved LVEF
1. The REDUCE-AMI trial showed no significant benefit of beta-blockers in reducing all-cause mortality or future myocardial infarction in patients wit...
Improving Left Ventricular Ejection Fraction in Heart Failure Patients: Insights from the HF-OPT Study
The HF-OPT study investigated the improvement of left ventricular ejection fraction (LVEF) beyond 90 days in patients with newly diagnosed heart failu...
AI in Cardiovascular Medicine: JACC Review
Overview: This review discusses the use and future directions of AI in cardiology, focusing on areas like electrocardiography, telemetry and wearables...
2024 ACC Peripheral Artery Disease (PAD) Guidelines
Collaborative vascular care is emphasized to address health disparities, gaps in medical therapy, structured exercise, and good foot care along with a...
2024 ACC/AHA Guidelines on Hypertrophic Cardiomyopathy
2024 HCM Guidelines Focus on Cardiac Myosin Inhibitors and Exercise
DOACs: When direct oral anticoagulants should not be used?
Key Points:
Positive Aspects of DOACs: DOACs are acknowledged for their convenience, efficacy, and safety in conditions like atri...
Cath: NPO vs Eating before Heart Cath
Background: Traditional practice requires fasting before cardiac catheterization, but there's no evidence to support it.
Objective: This study c...
Stable CAD and Angina: PCI without medical therapy as first treatment (ORBITA-2)
Key Points
In patients not taking antianginal meds, PCI alleviated some—but not all—symptoms
Background:
...
Acute CHF: GDMT Up-titration After Hospitalization for Acute HF (STRONG-HF Trial)
Study: STRONG-HF trial examined rapid up-titration of heart failure medications (GDMT) after hospitalization.
Goal: Reach optimal GDMT doses wit...
LIPIDS: Treat to Target or with High Intensity (LODESTAR Trial)
Key Points from "Treat to Target or With Intensity? Both Statin Tactics Cut MACE: LODESTAR":
The study compares two strategies for managing LDL...
Tricuspid Regurgitation: TEER for severe TR (Triluminate Pivotal Trial)
Key Points of the Study:
T-TEER with the TriClip device significantly improved health status in patients with severe tricuspid regurgitation (TR...
PAD: PROMISE II Trial: Deep-Vein Arterialization Shows Promise for No-Option CLTI Patients.
Key Points from PROMISE 2 Trial:
• Problem: 20% of CLTI patients have no revascularization options, leading to amputations.
• Solution: Tr...
Degenerative MR: Two Choices now for Mitral Transcatheter Repair (TEER): Clasp IID Trial
Key Points from this trial:
The CLASP IID trial, the first randomized controlled trial comparing the PASCAL system and the MitraClip syst...
Sinus Node Disease: DANPACE II trial: Study Debunks Pacing Myth: Minimizing Pacing Doesn't Curb A-Fib
Key points of the DANPACE II study on atrial pacing and atrial fibrillation in sinus node dysfunction:
1. Minimizing atrial pacing in pacemakers...
CAD: Coronary Artery Disease Updates in 2023
Key Points of Coronary Artery Disease Studies in 2023:
• ORBITA-2: Confirmed PCI's role in relieving angina symptoms for stable patients.
...
CHF: Major News and Trial Updates in CHF in 2023
A quick rundown of the key developments:
Trials:
Policy and Guidelines:
Other Highlights:
Valvular HD: 2023 Structural Highlights
Focus on Valves:
Challenges and Future Directions:
Overall, 2023 was a pivotal year for structural heart disease, with advancements in val...
PAD: Peripheral Arterial Disease Updates from 2023
Key Points of Endovascular Procedures and Devices in 2023:
FDA Actions:
CLTI Debate:
Other Developments:
Future Outlook:
Electrophysiology: Important EP Updates from 2023
Heart Rhythm 2023: Innovations in Ablation, Devices, and Conduction System Pacing.
Catheter Ablation and LAAO Advance:
Medical Therapies:...
Afib: FRAIL-AF Trial: Anticoagulation in Frail Older Patients with Afib
Key findings of the FRAIL-AF trial:
* Switching from vitamin K antagonist (VKA) to non-vitamin K antagonist oral anticoagulant (NOAC) th...
CHF: Semaglutide in HFpEF across obesity classes (STEP-HFpEF trial)
Summary of the STEP-HFpEF trial 2023 published in Nature Medicine
Overall, the STEP-HFpEF trial showed that semaglutide is a promising treatment...
Acute MI: Complete or Culprit-Only PCI in Older Patients with MI (FIRE trial)
Key points of the FIRE trial:
In conclusion, the study found that complete revascularization is beneficial in older patients with myocar...
CAD: ACC/AHA 2023 Chronic Coronary Disease Guideline Key Points: J Am Coll Cardiol. 2023 Aug, 82 (9) 956–960
These are the key points from this 2023 ACC/AHA guideline in managing chronic coronary disease.
Reference article: https:...
Cardiomyopathy: TTR Amyloid: efficacy and safety of acoramidis in transthyretin amyloid cardiomyopathy - ATTRibute-CM Trial, ESC Meeting August 2023
The ATTRibute-CM trial was a randomized, double-blind, placebo-controlled trial that evaluated the efficacy and safety of acoramidis in patients with...
Cardiac arrest: Expedited transfer to a cardiac arrest center for non-ST-elevation out-of-hospital cardiac arrest-The ARREST trial: The Lancet, August 2023
Key Points from ARREST trial findings:
Link to the reference article:
https://doi.org/10.1016/S0140-6736(23)01351-X
Infective Endocarditis: 2023 ESC Guidelines for the management of endocarditis in European Heart Journal
Here is a summary of the key points from the 2023 ESC guidelines for the management of endocarditis:
Link to Reference article:
LAA: Comparison of Initial Antithrombotic Regimens after Left Atrial Appendage Occlusion: JACC Aug 2023
This review highlights the following points:
There are different ways to prevent blood clots in patients who have undergone LAAO for atr...
CAD: Low-Dose Colchicine for Secondary Prevention of CAD: JACC Aug 2023
The review article was published in the Journal of the American College of Cardiology in August 2023 and was co-authored by Dr. Kyle Nelson, Dr. Valen...
CAD: A Practical Approach to Left Main Coronary Artery Disease 2022
LM CAD treatment needs sophisticated decision-making. Recent clinical practice standards guide clinicians; however, treating individual individuals mi...
PAD: Screening for Asymptomatic Carotid Artery Stenosis 2021
Screening for Asymptomatic Carotid Artery Stenosis in the General Population: Updated Evidence Report and Systematic Review for the US Preventive Serv...
Cardiomyopathy: Cardiac Amyloidosis-2020 Update
The understanding, diagnosis, and treatment options for transthyretin (TTR) amyloid is rapidly evolving. American Heart Association published a statem...